StockData
Recursion Pharmaceuticals, Inc. logo

Recursion Pharmaceuticals, Inc. (RXRX) stock

RXRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 8/302% below fair value
$2.90−0.28 (-8.79%)

Close on Nov 16, 2026Market cap $1.56BP/E –Yield –

Recursion Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Recursion Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2026 was -945.9%. For fiscal 2025 it was -863.4%, against -788.0% the year before. The highest annual figure on record is -601.0% in fiscal 2022.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-863.4%−75.3
FY2024Dec 31, 2024-788.0%−52.0
FY2023Dec 31, 2023-736.0%−134.9
FY2022Dec 31, 2022-601.0%+1231.1
FY2021Dec 31, 2021-1832.2%+363.8
FY2020Dec 31, 2020-2196.0%+472.3
FY2019Dec 31, 2019-2668.3%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-1708.0%−813.8
Q1 FY2026Mar 31, 2026-1815.6%−442.3
Q4 FY2025Dec 31, 2025-304.2%+3631.2
Q3 FY2025Sep 30, 2025-3135.3%−2767.9
Q2 FY2025Jun 30, 2025-894.2%−217.7
Q1 FY2025Mar 31, 2025-1373.3%−710.8
Q4 FY2024Dec 31, 2024-3935.5%−3081.6
Q3 FY2024Sep 30, 2024-367.5%+515.6
Q2 FY2024Jun 30, 2024-676.6%+19.9
Q1 FY2024Mar 31, 2024-662.4%−124.0
Q4 FY2023Dec 31, 2023-853.9%−433.5
Q3 FY2023Sep 30, 2023-883.1%−423.8
Q2 FY2023Jun 30, 2023-696.4%+157.9
Q1 FY2023Mar 31, 2023-538.4%+511.3
Q4 FY2022Dec 31, 2022-420.4%+2143.1
Q3 FY2022Sep 30, 2022-459.3%+1412.4
Q2 FY2022Jun 30, 2022-854.3%+848.4
Q1 FY2022Mar 31, 2022-1049.7%+149.3
Q4 FY2021Dec 31, 2021-2563.5%−1606.0
Q3 FY2021Sep 30, 2021-1871.7%+457.4
Q2 FY2021Jun 30, 2021-1702.7%+8481.7
Q1 FY2021Mar 31, 2021-1198.9%+29507.7
Q4 FY2020Dec 31, 2020-957.5%–
Q3 FY2020Sep 30, 2020-2329.1%–
Q2 FY2020Jun 30, 2020-10184.4%–
Q1 FY2020Mar 31, 2020-30706.7%–

More Recursion Pharmaceuticals figures

See a number that looks wrong?